Skip to main content
Log in

Weakening of the hyperthermic effect of prostaglandin E2 by cholinomimetics, monoamines, and calcium ions

  • Pharmacology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Experiments on unanesthetized rats showed that the hyperthermic effect of prostaglandin E2 (PG-E2) is not prevented by aspirin, but can be considerably weakened by injection of arecoline, noradrenalin, serotonin, histamine, and CaCl2 into the lateral ventricles of the brain or by intraperitoneal injection of eserine. Experiments on unanesthetized rabbits showed that arecoline and nicotine have a similar action on PG-E2-induced hyperthermia if injected into the 3rd ventricle. Effects of serotonin and arecoline also were found when reinjected into the cerebral ventricles. In the center for heat loss there are evidently mechanisms which incorporate cholinergic neurons whose activity is not totally inhibited by prostaglandins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature Cited

  1. L. Kh. Allikmets, V. A. Vakhing, and I. P. Lapin, Zh. Vyssh. Nerv. Deyat., No. 6, 1044 (1968).

    Google Scholar 

  2. Yu. S. Borodkin, N. A. Losev, and V. A. Krauz, Farmakol. Toksikol., No. 3, 259 (1970).

    Google Scholar 

  3. V. N. Gurin, Yu. I. Bogritsevich, A. I. Kubarko, et al., in: The Pharmacology and Toxicology of New Products of Chemical Synthesis [in Russian], Minsk (1975), p. 84.

  4. V. N. Gurin, A. I. Kubarko, Yu. I. Bogritsevich, et al., in: Proceedings of the 12th Congress of the I. P. Pavlov All-Union Physiological Society [in Russian], Tbilisi (1975), p. 171.

  5. V. N. Gurin, A. I. Kubarko, Yu. I. Bogritsevich, et al., in: Proceedings of the 4th All-Union Congress of Pharmacologists [in Russian], Leningrad (1976), p. 56.

  6. W. Feldberg and P. N. Saxena, J. Physiol. (London),219, 547 (1971).

    Google Scholar 

  7. W. Feldberg and P. N. Saxena, J. Physiol. (London),219, 739 (1971).

    Google Scholar 

  8. W. Feldberg and A. S. Milton, in: Pharmacology of Thermoregulation. Symposium, Basel (1973), p. 302.

  9. R. F. Hellon, Pharmacol. Rev.,26, 283 (1975).

    Google Scholar 

  10. B. Kandasamy and J. Girault, in: Temperature Regulation and Drug Action (Proceedings of Symposium), Basel (1975), p. 124.

  11. H. Laburn, C. J. Woolf, G. H. Willies, et al., Neuropharmacology,14, 405 (1975).

    Google Scholar 

  12. J. M. Lipton and G. P. Trzcinka, Am. J. Physiol.,231, 1638 (1976).

    Google Scholar 

  13. A. S. Milton and S. Wendlandt, J. Physiol. (London),218, 325 (1971).

    Google Scholar 

  14. R. D. Myers and T. L. Yaksh, J. Physiol. (London),218, 609 (1971).

    Google Scholar 

  15. J. T. Stitt, J. Physiol. (London),232, 163 (1973).

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gurin, V.N., Tsaryuk, V.V. & Tret'yakovich, A.G. Weakening of the hyperthermic effect of prostaglandin E2 by cholinomimetics, monoamines, and calcium ions. Bull Exp Biol Med 87, 151–154 (1979). https://doi.org/10.1007/BF00833975

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00833975

Key Words

Navigation